Loading stock research

Accuray Incorporated

ARAY

HealthcareNASDAQUS

Sign in to save

$0.3419

-$0.0236 (-6.46%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

ARAY News

News and disclosures filtered by period, publisher, and event group.

8 / 8

Filter options

Results

Select a headline to open the full news page in the app.

May 29, 2026, 4:10 PMprnewswire.comOfficialARAY

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

Company announcementsProspectus, capital raise, listing

MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.

May 15, 2026, 4:05 PMprnewswire.comARAY

Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer

Company announcements

MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform.

May 7, 2026, 4:41 AMseekingalpha.comARAY

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

Company announcementsFinancial reports

Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript

May 6, 2026, 4:05 PMprnewswire.comARAY

Accuray Reports Fiscal 2026 Third Quarter Financial Results

Company announcementsFinancial reports

MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.

Apr 22, 2026, 4:05 PMprnewswire.comARAY

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Company announcementsFinancial reports

MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m.

Apr 22, 2026, 4:40 AMdefenseworld.netARAY

Accuray (ARAY) to Release Quarterly Earnings on Wednesday

Company announcementsFinancial reports

Accuray (NASDAQ: ARAY - Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $111.90 million for the quarter. Parties are encouraged to explore the company's upcoming Q3 2026 earning overview page for

Apr 6, 2026, 9:00 AMprnewswire.comARAY

Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

Company announcementsManagement

MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026.

Apr 2, 2026, 4:49 AMdefenseworld.netOfficialARAY

Short Interest in Accuray Incorporated (NASDAQ:ARAY) Expands By 20.6%

Company announcements

Accuray Incorporated (NASDAQ: ARAY - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 13th, there was short interest totaling 6,598,752 shares, a growth of 20.6% from the February 26th total of 5,471,116 shares. Approximately 5.8% of the shares of the company are sold

Loading disclosure news